| pubmed-article:15665550 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15665550 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15665550 | lifeskim:mentions | umls-concept:C0019004 | lld:lifeskim |
| pubmed-article:15665550 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:15665550 | lifeskim:mentions | umls-concept:C0041455 | lld:lifeskim |
| pubmed-article:15665550 | lifeskim:mentions | umls-concept:C0035086 | lld:lifeskim |
| pubmed-article:15665550 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:15665550 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:15665550 | pubmed:dateCreated | 2005-3-8 | lld:pubmed |
| pubmed-article:15665550 | pubmed:abstractText | Useful markers of bone resorption are needed for hemodialysis patients with renal osteodystrophy. This study investigated the use of a new immunoassay for cross-linked N-terminal telopeptide of type 1 collagen to assess bone changes in hemodialysis patients. | lld:pubmed |
| pubmed-article:15665550 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15665550 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15665550 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15665550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15665550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15665550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15665550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15665550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15665550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15665550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15665550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15665550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15665550 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15665550 | pubmed:issn | 1660-2110 | lld:pubmed |
| pubmed-article:15665550 | pubmed:author | pubmed-author:YamagataZenta... | lld:pubmed |
| pubmed-article:15665550 | pubmed:author | pubmed-author:YoriokaNoriak... | lld:pubmed |
| pubmed-article:15665550 | pubmed:author | pubmed-author:MizutaniTakas... | lld:pubmed |
| pubmed-article:15665550 | pubmed:author | pubmed-author:NakashimaAyum... | lld:pubmed |
| pubmed-article:15665550 | pubmed:author | pubmed-author:TakasugiNorih... | lld:pubmed |
| pubmed-article:15665550 | pubmed:author | pubmed-author:UenoToshinori... | lld:pubmed |
| pubmed-article:15665550 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:15665550 | pubmed:volume | 99 | lld:pubmed |
| pubmed-article:15665550 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15665550 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15665550 | pubmed:pagination | c78-85 | lld:pubmed |
| pubmed-article:15665550 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:meshHeading | pubmed-meshheading:15665550... | lld:pubmed |
| pubmed-article:15665550 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15665550 | pubmed:articleTitle | Serum cross-linked N-terminal telopeptide of type I collagen for evaluation of renal osteodystrophy in hemodialysis patients. | lld:pubmed |
| pubmed-article:15665550 | pubmed:affiliation | Department of Internal Medicine, Hakuai Hospital, Kure, Japan. | lld:pubmed |
| pubmed-article:15665550 | pubmed:publicationType | Journal Article | lld:pubmed |
